XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results
Go back to XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.76 -0.22 (7.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.98 | 52 Week High | $1.75 | |||
| Open | $2.83 | 52 Week Low | $0.64 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $0.00 | |||
| Volume | 4,409 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.76 -0.22 (7.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.98 | 52 Week High | $1.75 | |||
| Open | $2.83 | 52 Week Low | $0.64 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $0.00 | |||
| Volume | 4,409 | |||||

